nach oben

Endocrine

Erschienen in:

30.05.2018 | Original Article

Gender-specific differences of interaction between cadmium exposure and obesity on prediabetes in the NHANES 2007–2012 population

verfasst von: Fei Jiang, Xueyuan Zhi, Miao Xu, Bingyan Li, Zengli Zhang

Erschienen in: Endocrine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Data from National Health and Nutrition Examination Survey (NHANES) for the years 2007–2012 were used to evaluate the interactions of cadmium (Cd) exposure with being overweight/obesity on the risk of prediabetes among adults 20 years older.

Methods

A total of 3552 subjects were included in the analysis. Urinary cadmium levels (UCd) was used as a biomarker for long-term exposure to Cd. Additive interaction was estimated using relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP) and synergy index (S).

Results

Following covariates adjustments, we found significant associations of UCd with higher prediabetes prevalence, and this association was more apparent in males (Q4 vs Q1: OR = 1.95, 95%CI: 1.34–2.84); while overweight/obesity was associated with prediabetes both in males and in females. Additionally, there was a significant interaction between Cd exposure and being overweight/obesity on prediabetes risk among males (RERI = 1.18, 95% CI: 0.42–1.93; AP = 0.35, 95% CI: 0.12–0.58; S = 2.00, 95% CI: 0.92–4.34).

Conclusions

Our results suggest that being overweight/obesity may substantially amplify the adverse effects of long-term cadmium exposure on prediabetes risk, and this interaction is more severe in male adults. Further studies are needed to confirm these findings.

International Diabetes Federation, IDF Diabetes Atlas, (2018) http://www.diabetesatlas.org/. Accessed 9 April 2018

C.M. Edwards, K. Cusi, Prediabetes: a worldwide epidemic. Endocrinol. Metab. Clin. North. Am. 45, 751–764 (2016)CrossRefPubMed

B. Brannick, S. Dagogo-Jack, Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction. Endocrinol. Metab. Clin. North. Am. 47, 33–50 (2018)CrossRefPubMed

A.G. Tabak, C. Herder, W. Rathmann, E.J. Brunner, M. Kivimaki, Prediabetes: a high-risk state for diabetes development. Lancet 379, 2279–2290 (2012)CrossRefPubMedPubMedCentral

K.A. Thayer, J.J. Heindel, J.R. Bucher, M.A. Gallo, Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ. Health Perspect. 120, 779–789 (2012)CrossRefPubMedPubMedCentral

I. Iavicoli, L. Fontana, A. Bergamaschi, The effects of metals as endocrine disruptors. J. Toxicol. Environ. Health B. Crit. Rev. 12, 206–223 (2009)CrossRefPubMed

S. Satarug, S.H. Garrett, M.A. Sens, D.A. Sens, Cadmium, environmental exposure, and health outcomes. Environ. Health Perspect. 118, 182–190 (2010)CrossRefPubMed

S. Satarug, Long-term exposure to cadmium in food and cigarette smoke, liver effects and hepatocellular carcinoma. Curr. Drug. Metab. 13, 257–271 (2012)CrossRefPubMed

A.A. Tinkov, T. Filippini, O.P. Ajsuvakova, J. Aaseth, Y.G. Gluhcheva, J.M. Ivanova, G. Bjorklund, M.G. Skalnaya, E.R. Gatiatulina, E.V. Popova, O.N. Nemereshina, M. Vinceti, A.V. Skalny, The role of cadmium in obesity and diabetes. Sci. Total Environ. 601-602, 741–755 (2017)CrossRefPubMed

10.

J.C. Erie, J.A. Good, J.A. Butz, D.O. Hodge, J.S. Pulido, Urinary cadmium and age-related macular degeneration. Am. J. Ophthalmol. 144, 414–418 (2007)CrossRefPubMed

11.

G.L. Ginsberg, Cadmium risk assessment in relation to background risk of chronic kidney disease. J. Toxicol. Environ. Health A 75, 374–390 (2012)CrossRefPubMed

12.

J.M. Lavado-Garcia, L.M. Puerto-Parejo, R. Roncero-Martin, J.M. Moran, J.D. Pedrera-Zamorano, I.J. Aliaga, O. Leal-Hernandez, M.L. Canal-Macias, Dietary intake of cadmium, lead and mercury and its association with bone health in healthy premenopausal women. Int. J. Environ. Res. Public. Health 14, 1437 (2017).

13.

S.C. Larsson, N. Orsini, A. Wolk, Urinary cadmium concentration and risk of breast cancer: a systematic review and dose-response meta-analysis. Am. J. Epidemiol. 182, 375–380 (2015)CrossRefPubMed

14.

J.C. Han, S.Y. Park, B.G. Hah, G.H. Choi, Y.K. Kim, T.H. Kwon, E.K. Kim, M. Lachaal, C.Y. Jung, W. Lee, Cadmium induces impaired glucose tolerance in rat by down-regulating GLUT4 expression in adipocytes. Arch. Biochem. Biophys. 413, 213–220 (2003)CrossRefPubMed

15.

M.M. El, M.R. Raja, X. Zhang, K.W. MacRenaris, S. Bhatt, X. Chen, M. Urbanek, T.V. O’Halloran, W.J. Lowe, Accumulation of cadmium in insulin-producing beta cells. Islets 4, 405–416 (2012)CrossRef

16.

K.D. Chapatwala, M. Hobson, D. Desaiah, B. Rajanna, Effect of cadmium on hepatic and renal gluconeogenic enzymes in female rats. Toxicol. Lett. 12, 27–34 (1982)CrossRefPubMed

17.

S. Mohammad, J. Ahmad, Management of obesity in patients with type 2 diabetes mellitus in primary care. Diabetes Metab. Syndr. 10, 171–181 (2016)CrossRefPubMed

18.

L. Khaodhiar, S. Cummings, C.M. Apovian, Treating diabetes and prediabetes by focusing on obesity management. Curr. Diab. Rep. 9, 348–354 (2009)CrossRefPubMedPubMedCentral

19.

E.J. Henriksen, M.K. Diamond-Stanic, E.M. Marchionne, Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 51, 993–999 (2011)CrossRefPubMed

20.

N. Esser, S. Legrand-Poels, J. Piette, A.J. Scheen, N. Paquot, Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105, 141–150 (2014)CrossRefPubMed

21.

J.A. Colacino, A.E. Arthur, K.K. Ferguson, L.S. Rozek, Dietary antioxidant and anti-inflammatory intake modifies the effect of cadmium exposure on markers of systemic inflammation and oxidative stress. Environ. Res. 131, 6–12 (2014)CrossRefPubMedPubMedCentral

22.

X. Nie, N. Wang, Y. Chen, C. Chen, B. Han, C. Zhu, Y. Chen, F. Xia, Z. Cang, M. Lu, Y. Meng, B. Jiang, J.M. D, Y. Lu, Blood cadmium in Chinese adults and its relationships with diabetes and obesity. Environ. Sci. Pollut. Res. Int. 23, 18714–18723 (2016)CrossRefPubMed

23.

G.G. Schwartz, D. Il’Yasova, A. Ivanova, Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 26, 468–470 (2003)CrossRefPubMed

24.

A. Wallia, N.B. Allen, S. Badon, M.M. El, Association between urinary cadmium levels and prediabetes in the NHANES 2005-2010 population. Int. J. Hyg. Environ. Health 217, 854–860 (2014)CrossRefPubMedPubMedCentral

25.

H.S. Son, S.G. Kim, B.S. Suh, D.U. Park, D.S. Kim, S.D. Yu, Y.S. Hong, J.D. Park, B.K. Lee, J.D. Moon, J. Sakong, Association of cadmium with diabetes in middle-aged residents of abandoned metal mines: the first health effect surveillance for residents in abandoned metal mines. Ann. Occup. Environ. Med. 27, 20 (2015)CrossRefPubMedPubMedCentral

26.

Z.A. Shaikh, T.T. Vu, K. Zaman, Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants. Toxicol. Appl. Pharmacol. 154, 256–263 (1999)CrossRefPubMed

27.

J. Liu, W. Qu, M.B. Kadiiska, Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol. Appl. Pharmacol. 238, 209–214 (2009)CrossRefPubMedPubMedCentral

28.

D.H. Lee, J.S. Lim, K. Song, Y. Boo, D.J. Jacobs, Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the U.S. population: results from the third National Health and Nutrition Examination Survey. Environ. Health Perspect. 114, 350–354 (2006)CrossRefPubMed

29.

G. Pizzino, N. Irrera, A. Bitto, G. Pallio, F. Mannino, V. Arcoraci, F. Aliquo, L. Minutoli, C. De Ponte, P. D’Andrea, F. Squadrito, D. Altavilla, Cadmium-induced oxidative stress impairs glycemic control in adolescents. Oxid. Med. Cell Longev. 2017, 6341671 (2017)PubMedPubMedCentral

30.

I. Abdelaziz, M.I. Elhabiby, A.A. Ashour, Toxicity of cadmium and protective effect of bee honey, vitamins C and B complex. Hum. Exp. Toxicol. 32, 362–370 (2013)CrossRefPubMed

31.

J. Mladenovic, B. Ognjanovic, N. Dordevic, M. Matic, V. Knezevic, A. Stajn, Z. Saicic, Protective effects of oestradiol against cadmium-induced changes in blood parameters and oxidative damage in rats. Arh. Hig. Rada Toksikol. 65, 37–46 (2014)CrossRefPubMed

32.

S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, I. Shimomura, Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 1752–1761 (2004)CrossRefPubMedPubMedCentral

33.

I. Savini, M.V. Catani, D. Evangelista, V. Gasperi, L. Avigliano, Obesity-associated oxidative stress: strategies finalized to improve redox state. Int. J. Mol. Sci. 14, 10497–10538 (2013)CrossRefPubMedPubMedCentral

34.

G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, B.M. Spiegelman, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409–2415 (1995)CrossRefPubMedPubMedCentral

35.

C. Phosat, P. Panprathip, N. Chumpathat, P. Prangthip, N. Chantratita, N. Soonthornworasiri, S. Puduang, K. Kwanbunjan, Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study. BMC Endocr. Disord. 17, 44 (2017)CrossRefPubMedPubMedCentral

36.

H.P. Kopp, C.W. Kopp, A. Festa, K. Krzyzanowska, S. Kriwanek, E. Minar, R. Roka, G. Schernthaner, Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler. Thromb. Vasc. Biol. 23, 1042–1047 (2003)CrossRefPubMed

37.

C. Holdstock, L. Lind, B.E. Engstrom, M. Ohrvall, M. Sundbom, A. Larsson, F.A. Karlsson, CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int. J. Obes. (Lond.). 29, 1275–1280 (2005)CrossRef

38.

E.S. Abd, A.M. Saiem, Impact of weight loss on oxidative stress and inflammatory cytokines in obese type 2 diabetic patients. Afr. Health Sci. 16, 725–733 (2016)CrossRef

39.

A. Navas-Acien, E. Selvin, A.R. Sharrett, E. Calderon-Aranda, E. Silbergeld, E. Guallar, Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109, 3196–3201 (2004)CrossRefPubMed

40.

Y.S. Lin, D. Rathod, W.C. Ho, J.J. Caffrey, Cadmium exposure is associated with elevated blood C-reactive protein and fibrinogen in the U. S. population: the third national health and nutrition examination survey (NHANES III, 1988-1994). Ann. Epidemiol. 19, 592–596 (2009)CrossRefPubMed

41.

B.M. Cheung, K.L. Ong, L.Y. Wong, Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999-2004. Int. J. Cardiol. 135, 156–161 (2009)CrossRefPubMed

42.

M. Kippler, K. Engstrom, S.J. Mlakar, M. Bottai, S. Ahmed, M.B. Hossain, R. Raqib, M. Vahter, K. Broberg, Sex-specific effects of early life cadmium exposure on DNA methylation and implications for birth weight. Epigenetics 8, 494–503 (2013)CrossRefPubMedPubMedCentral

43.

Q. Ba, M. Li, P. Chen, C. Huang, X. Duan, L. Lu, J. Li, R. Chu, D. Xie, H. Song, Y. Wu, H. Ying, X. Jia, H. Wang, Sex-dependent effects of cadmium exposure in early life on gut microbiota and fat accumulation in mice. Environ. Health Perspect. 125, 437–446 (2017)PubMedCrossRef

44.

C. Nagata, Y. Nagao, C. Shibuya, Y. Kashiki, H. Shimizu, Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol. Biomark. Prev. 14, 705–708 (2005)CrossRef

45.

S. De Craemer, K. Croes, N. van Larebeke, S. De Henauw, G. Schoeters, E. Govarts, I. Loots, T. Nawrot, V. Nelen, E. Den Hond, L. Bruckers, Y. Gao, W. Baeyens, Metals, hormones and sexual maturation in Flemish adolescents in three cross-sectional studies (2002-2015). Environ. Int. 102, 190–199 (2017)CrossRefPubMed

46.

K. Esposito, G. Bellastella, M.I. Maiorino, D. Giugliano, Particulate matter air pollution: individual choices for improving cardiometabolic well-being. Endocrine 59, 495–498 (2018)CrossRefPubMed

Titel: Gender-specific differences of interaction between cadmium exposure and obesity on prediabetes in the NHANES 2007–2012 population
verfasst von: Fei Jiang
Xueyuan Zhi
Miao Xu
Bingyan Li
Zengli Zhang
Publikationsdatum: 30.05.2018
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1623-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

Metabolic and bone effects of high-fat diet in adult zebrafish

Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations

Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome

Increasing soft tissue thickness does not affect trabecular bone score reproducibility: a phantom study